Bicycle Therapeutics plc (BCYC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 490.5M |
| Enterprise Value | -120.09M |
| P/E Ratio | -1.41 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 4.38 |
| Price/Book Ratio | 0.53 |
| Enterprise/Revenue | -3.73 |
| Enterprise/EBITDA | 1.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -3.11 |
| Operating Margin | -3.44 |
| Return On Assets | -0.31 |
| Return On Equity | -0.33 |
| Revenue | 72.59M |
| Revenue/Share | 0.88 |
| Gross Profit | 72.59M |
| EBITDA | -212.18M |
| Net Income | -218.96M |
| Diluted EPS | -3.16 |
| Total Cash | 510.05M |
| Total Cash/Share | 7.31 |
| Total Debt | 13.68M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 12.08 |
| Book Value Per Share | 7.31 |
| 52-Week Change | -52.05 |
| 52-Week High | 9.16 |
| 52-Week Low | 3.8 |
| Moving Average 50 Days | 4.2 |
| Moving Average 200 Days | 5.61 |
| Average Volume | 436,653 |
| Shares Outstanding | 69.39M |
| % Held by Institutions | 53.76 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |